Noteworthy, the final safety opinion released in October 2023 by the European Unions Scientific Committee on Consumer Safety (SCCS), specifically addressing fullerenes, hydroxylated fullerenes and their hydrated nanoscale forms (SCCS/1649/23), stands out for its significance [14]
Already in effect (January 1, 2026): Standard PA decisions within 7 calendar days (down from 14) Urgent PA decisions within 72 hours Specific denial reasons required on every denial (not just not medically necessary) Applies to Medicare Advantage, Medicaid managed care, CHIP, and ACA Marketplace plans Coming March 31, 2026: Payers must publicly report PA metrics for calendar year 2025: approval/denial rates, average decision times, and appeals outcomes Providers will be able to compare payer performance for the first time Coming January 1, 2027: FHIR-based Prior Authorization APIs required providers check PA requirements, submit requests, and receive decisions electronically through their EHR Expected to reduce average PA processing time from days to minutes for standard requests Medicare WISeR Model (live in AZ and WA): The Wasteful and Inappropriate Services Reduction pilot launched January 2026 in six states including Arizona and Washington
Researchers often search what is dsip for men when exploring scientific information regarding peptide investigations involving male-focused biological research models
Eupaformosanin Induces Apoptosis and Ferroptosis through Ubiquitination of Mutant P53 in Triple-Negative Breast Cancer
